Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

Press releases published on June 2, 2026

14 hours ago

Propanc Biopharma’s CEO Attends Keynote Address, “Rejuvenation and Health: Science for an Ageing Society,” at the University of Granada, Spain

Indeterminate GlobeNewswire

15 hours ago

Crinetics’ Paradigm-Shifting Portfolio and Pipeline on Display at ENDO 2026 with Six Presentations

Indeterminate GlobeNewswire

16 hours ago

Philips announces exchange ratio for 2025 dividend

Indeterminate GlobeNewswire

16 hours ago

Comen Launches Latin American Medical Solutions at Hospitalar 2026

Indeterminate GlobeNewswire

16 hours ago

FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression candidate

Indeterminate GlobeNewswire

17 hours ago

Nanobiotix Joins the Euronext Tech Leaders Index

Indeterminate GlobeNewswire

17 hours ago

Nanobiotix rejoint l'indice Euronext Tech Leaders

Indeterminate GlobeNewswire

18 hours ago

OXB Capital Markets Event

Indeterminate GlobeNewswire

18 hours ago

Greywolf Therapeutics reports durable clinical responses with first-in-class oral ERAP1 inhibitor GRWD5769 across six solid tumor types

Indeterminate GlobeNewswire

18 hours ago

Launch of TechBio firm, Lucera, brings decision intelligence to drug development, making it more predictable, more evidence-grounded, and more efficient

Indeterminate GlobeNewswire

18 hours ago

Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris

Indeterminate GlobeNewswire

18 hours ago

Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris

Indeterminate GlobeNewswire

Jun. 2, 2026

Santhera gibt die Erteilung des Orphan-Drug-Status und der Prioritätsprüfung für AGAMREE® (Vamorolon) in Südkorea bekannt

Indeterminate GlobeNewswire

Jun. 2, 2026

Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea

Indeterminate GlobeNewswire

Jun. 2, 2026

Rapid Nutrition Expands Agentic AI Integration Across Consumer Wellness Ecosystem

Indeterminate GlobeNewswire